Erratum: Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy (Science DOI: 10.1126/science.aar3593)

R. Cristescu, R. Mogg, M. Ayers, A. Albright, E. Murphy, J. Yearley, X. Sher, X. Q. Liu, H. Lu, M. Nebozhyn, C. Zhang, J. K. Lunceford, A. Joe, J. Cheng, A. L. Webber, N. Ibrahim, E. R. Plimack, P. A. Ott, T. Y. Seiwert, A. RibasT. K. McClanahan, J. E. Tomassini, A. Loboda, D. Kaufman

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the Research Article “Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy,” table S2 in the supplementary material has been expanded to include the raw NanoString counts for the housekeeping and predictor genes that make up the GEP score, as well as the weighting algorithm used to determine the score (table S2B). These data were added per journal.

Original languageEnglish (US)
Article numbereaax1384
JournalScience
Volume363
Issue number6430
DOIs
StatePublished - Mar 1 2019
Externally publishedYes

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Erratum: Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy (Science DOI: 10.1126/science.aar3593)'. Together they form a unique fingerprint.

Cite this